Participated · Equity · Jun 2026

Hoola Health is described in the coverage as a paediatric healthcare startup. Beyond its sector focus and the recent $5 million fundraise, the article does not provide details on its products, services, founding year, location, or operating metrics. The coverage likewise does not report revenue, user counts, or other financial metrics. No future roadmap or concrete plans were disclosed in the available article.

Participated · Series A · Jan 2026

Nivaan Care offers a specialized healthcare platform that combines interventional pain management, physiotherapy, and coordinated patient support to create a standardized care pathway for chronic pain sufferers. The company differentiates itself from generalist settings through a clinician-centric, outcomes-measured approach intended to deliver consistent improvements for patients. By centralizing diagnosis, treatment, and follow-up, Nivaan aims to address the fragmented access that affects an estimated 270 million Indians living with chronic pain. Investor commentary highlights the team’s clinical depth and its ability to scale specialty care without sacrificing quality. With fresh capital, the company plans to accelerate national expansion, open additional locations, and deepen its platform capabilities to make specialist pain care more accessible and repeatable. Although specific revenue or user metrics were not disclosed, the sizable market opportunity and operational focus have attracted multiple healthcare-focused investors.

Led · Seed · Oct 2025

Everbright Health is a managed services platform built to streamline clinical and administrative workflows for psychiatrists, psychologists, and therapists. Its AI-driven operations system identifies eligible patients, secures prior authorizations, manages billing, ensures compliance, and oversees treatment delivery. By partnering rather than competing with clinicians, the company enables practices to incorporate FDA-approved interventions such as Transcranial Magnetic Stimulation (TMS) and SPRAVATO. Everbright follows an asset-light model supported by technology and operational teams in the United States and India. Within three months of launch it had signed contracts with more than 75 behavioral-health providers across seven U.S. markets. Fresh capital will be used to enhance the platform’s technology, accelerate U.S. market expansion, and replicate its model for additional advanced therapies.

Participated · Series B · Dec 2024

TG0 is a London-based AI-hardware company that develops touch-sensitive and pressure-mapping technologies to improve human-machine interfaces. Its patented solutions enable ergonomic, intuitive, and responsive products that collect data from touch, pressure, and vibration. The company serves industries including automotive, medtech, consumer electronics and robotics. It partners with enterprises such as Novares, Zwift Ride, Italdesign and Somnium Space. TG0 plans to expand its offerings across industries and use the new funding to grow its global team and enhance capabilities from product design to mass manufacturing. CEO and co-founder Ming Kong said the round validates market appetite for AI-powered hardware and reinforces the company's commitment to transforming human-machine interactions globally. TG0 is a London-based developer of AI-powered human-machine interfaces that creates customizable AI-embedded products and touch-sensitive, pressure-responsive materials. Its products include smart pressure-sensing insoles and prosthetics and the company serves clients such as ZWIFT, Novares, Italdesign, Dashine, AIRBUS, and Futaba. TG0 holds patented technology that enables designers and manufacturers across consumer electronics, automotive, healthcare, audio, gaming, and fitness to build smarter, more sustainable, user-centric experiences. In Q4 2023 TG0 received a £2 million investment from NetMind, which will be used to rapidly scale technology and product development. TG0 is partnering with NetMind to integrate NetMind’s low-cost hardware, cloud computing platform, and FPGA-based AI frameworks, and the two firms will co-develop AI solutions on TG0’s platform. The collaboration also connects TG0 with research groups at King’s College London and Imperial College London, and TG0 plans to seek a new funding round later this year.

Participated · Series A · Jul 2024

Kins is a Boston-based digital-first hybrid physical therapy practice that combines virtual and in-person care to enable therapists and patients to collaborate on personalized care plans. The company operates a hybrid care platform for physical therapy delivery and coordination. Kins plans to use the Series A proceeds to accelerate development of its virtual and in-person care platform. The company also intends to expand into the Washington, D.C., Maryland, and Virginia markets. Led by CEO Dan Smith, Kins positions its model for collaboration with payers on value-based care delivery. The firm says it has proven its care model with patients, providers, and health systems. Kins operates a digital-first hybrid physical therapy model that combines in-home visits and virtual care to deliver patient-centric, 1-on-1 treatment. Founded in 2021 at Redesign Health and launched in New York in September 2021, Kins has expanded into Massachusetts and partners with payers and providers including Aetna, Cigna, UnitedHealthCare, Blue Cross Blue Shield, Harvard Pilgrim, and Optum Care. The company plans to use new financing to further develop its hybrid model and expand into additional markets while hiring and partnering in New York, Massachusetts, and other regions. Since launch, Kins reports 30% month-over-month growth, a 4.9 out of 5 patient satisfaction rating, 68% retention to care plan, and 71% clinical improvement per patient. Kins positions its approach as a solution to high clinic-centric dropout and therapist turnover by providing therapists autonomy, flexibility, and more time to build patient relationships.